Hydrocortisone in Hormone Replacement Therapy for Large Pituitary Neuroendocrine Tumors

Clinical trial NCT06679816 · RECRUITING

Trial details

NCT number: NCT06679816
Sponsor: Beijing Tiantan Hospital
Status: RECRUITING
Phase: Phase 4
Study type: INTERVENTIONAL

Pituitary Adenoma Pituitary Neuroendocrine Tumor

Start date: 2024-12-04
Primary completion: 2025-12-31
Enrollment: 882

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.